Both ALM and IPX operate within the critical-minerals theme that continues to draw investor interest, yet they reflect distinct risk levels and stages of development. Almonty Industries operates as an established tungsten producer, while IperionX focuses on building a domestic U.S. titanium supply chain. This comparison matters most for investors following defense, aerospace, and supply-chain security themes who want to balance a cash-flow positive miner against a higher-risk, pre-revenue growth opportunity. Their relative positioning offers useful perspective on where each stands today.
ALM, or Almonty Industries Inc., mines, processes, and ships tungsten concentrate from assets that include the Sangdong project in South Korea and the Panasqueira mine in Portugal. Tungsten serves key roles in defense, aerospace, and semiconductor applications, and the company positions itself as a non-Chinese supplier amid China’s dominance in global output. Almonty completed a U.S. listing in 2025 and has raised further capital to support expansion, including work on a tungsten oxide facility.
Market action has shown volatility. The stock reached a 52-week high earlier before retreating from a meaningful portion of those gains amid shifting sentiment toward high-multiple critical-minerals equities. Even with that pullback, trailing-twelve-month revenue has grown sharply, and recent quarters reflect improved financial results that support a generally positive stance among sell-side analysts. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
IPX, or IperionX Limited, develops titanium metal and critical materials through patented, lower-carbon processes that convert titanium minerals and scrap into alloys, powders, and components. Based in North Carolina, the company advances the Titan project in Tennessee and the Virginia Titanium Manufacturing Campus while trading on both Nasdaq and the Australian Securities Exchange.
IperionX remains pre-revenue and reports ongoing net losses as capacity builds, yet it has secured several U.S. defense-related awards in recent months, including Army task orders that support its domestic supply-chain approach. The stock faced pressure in recent weeks from a critical short-seller report that questioned technology scalability before recovering as shareholders expressed continued support for management. This sequence underscores both the potential catalysts and the higher uncertainty tied to the name.
The most obvious distinction lies in maturity. ALM produces revenue from operating mines and moves toward consistent profitability, which supplies a clearer fundamental foundation. IPX is pre-revenue, so its valuation rests almost entirely on expectations for future production and defense-contract momentum rather than current earnings.
Growth drivers differ as well. ALM benefits from Western initiatives to diversify tungsten supply away from China, while IPX aligns with U.S. efforts to restore domestic titanium capacity for aerospace and defense uses. Both face concentration risks: ALM depends on tungsten pricing and project execution, whereas IPX contends with technology scaling and financing needs as it advances from pilot to commercial stages. Sentiment toward each has eased from recent peaks, but IPX has experienced sharper volatility, including the short-seller episode, while ALM’s decline has tracked broader de-risking across critical-materials equities.
Considering trend consistency, stability, and relative positioning, Tickeron’s AI currently leans toward ALM over IPX. The assessment remains probabilistic rather than absolute. ALM’s established revenue base, improving profitability path, and strategic tungsten positioning offer a steadier platform than IPX’s still-developing commercial ramp. IPX carries meaningful upside potential linked to defense catalysts, yet its pre-revenue status and recent volatility add greater uncertainty. On balance, the model favors ALM as the more consistent option in the present environment.
When comparing names like these, I regularly review the Trending AI Robots page to see which automated strategies align with current market conditions. The platform highlights bots that have performed well recently across different risk levels and timeframes, helping me match approaches to my own objectives without having to screen every option manually. This filtered view saves time and offers practical ideas for both shorter-term trades and longer-term holdings.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where IPX declined for three days, in 205 of 240 cases, the price declined further within the following month. The odds of a continued downward trend are 85%.
The Momentum Indicator moved below the 0 level on November 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IPX as a result. In 48 of 59 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 81%.
The Moving Average Convergence Divergence Histogram (MACD) for IPX turned negative on November 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 37 similar instances when the indicator turned negative. In 30 of the 37 cases the stock turned lower in the days that followed. This puts the odds of success at 81%.
The Aroon Indicator for IPX entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator entered the oversold zone -- be on the watch for IPX's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +17.52% 3-day Advance, the price is estimated to grow further. Considering data from situations where IPX advanced for three days, in 220 of 262 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
IPX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 64 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.783) is normal, around the industry mean (6.813). P/E Ratio (-7.050) is within average values for comparable stocks, (-0.701). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.026). Dividend Yield (0.000) settles around the average of (0.016) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (283.864).
The Tickeron Price Growth Rating for this company is 87 (best 1 - 100 worst), indicating slightly worse than average price growth. IPX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IPX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry OtherMetalsMinerals